Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Hari S Sharma

Hari S Sharma

Uppsala University Sweden

Sudhindra R Gadagkar

Sudhindra R Gadagkar

Midwestern University USA

John Varghese

John Varghese

University of California USA

Gjumrakch Aliev

Gjumrakch Aliev

GALLY International Biomedical Research Consulting LLC. USA

James B Ames

James B Ames

University of California USA

Thomas Rich

Thomas Rich

University of South Alabama USA

Teresa Duda

Teresa Duda

Salus University USA

Vasiliki Daikopoulou

Vasiliki Daikopoulou

R.G.C.C. S.A Greece

Neuropharmacology 2019

About Conference


Conference Series LLC Ltd is a renowned organization that organizes highly notable conferences Throughout the globe currently we are bringing forth "27th Global Experts Meeting on Neuropharmacology” (Neuropharmacology 2019) scheduled to be held during November 18-19, 2019 at Rome, Italy. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmacology and Neuropharmacology.

Conference Series LLC Ltd Organizes 3000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access Journals which contains over 70000 eminent personalities as editorial board members as reputed scientists and 1200+ Symposiums & Workshops.

Why to attend???

With members from around the world focused on learning about neuropharmacology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Neuropharmacology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Neuropharmacology are hallmarks of this conference.

Target Audience:

  • Neuropharmacology Students, Scientists
  • Neuropharmacology Researchers
  • Neuropharmacology Faculty
  • Medical Colleges
  • Neuropharmacology Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies

2019 Highlights:

  • 300+ Participation (70 Industry: 30 Academia)
  • 5+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings

Sessions/Tracks

Track 01: Neuroimmunology and Neuroinflammation

It deals with a branch of immunology concerned with the interactions between immunological and nervous system functions also associated autoimmune diseases. Encephalitis is acute inflammation of the brain resulting from a viral infection or an autoimmune disease. Transverse myelitis is a pathogenetically heterogeneous inflammatory disorder in which spinal cord is affected. Huntington disease is a progressive brain disorder that causes uncontrolled movements, emotional problems, and loss of thinking ability.

Related ConferencesNeuropharmacology Conferences | Pharmacology Conferences | Neuropharmacology Conferences 2019 | Global Neuropharmacology Meeting | Clinical Neuropharmacology | Pharmaceutical Conferences

24th World Congress on Pharmacology August 19-20, 2019 Vienna, Austria; 25th International Conference on Advanced Clinical Research and Clinical Trials September 16-17, 2019 Rome, Italy; 20th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Edinburgh, Scotland; 21st Annual European Pharma Congress May 20-22, 2019 Zurich, Switzerland; 19th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25-26, 2019 Berlin, Germany; 6th International Conference on Natural Products and Medicinal Plants Research June 24-25, 2019 Vienna, Austria; 6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance June 03-04, 2019 at London, UK; 22nd International Conference and Exhibition on Pharmaceutical Formulations July 04, 05 & 06, 2019 Valencia, Spain; 11th Annual Congress on Drug Formulation & Analytical Techniques November 11-12, 2019 Istanbul, Turkey; 7th European Biopharma Congress June 17-18, 2019 Stockholm, Sweden; 12th European Biosimilars Congress April 15-16, 2019 Berlin, Germany

Related Journals: Journal of Neuropharmacology | Journal of NeuroImmune Pharmacology | International Journal of Neuropharmacology | Neurochemistry & Neuropharmacology | Journal of Neuroscience and Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association, Kuwait Pharmaceuticl Association

Track 02: Neural Stem Cell

Neural stem cells (NSCs) offer a unique and powerful tool for basic research and regenerative medicine. To date the need to accomplish this has just been met to some degree for neurons got from embryonic undeveloped cells or iPS cells, and still, after all that the information is not of a quality to justify clinical trials. The issue is that, while the cells that can be made in the lab resemble the ones required, they frequently do not have certain fundamental attributes.

Related ConferencesNeuropharmacology Conferences | Pharmacology Conferences | Neuropharmacology Conferences 2019 | Global Neuropharmacology Meeting | Clinical Neuropharmacology | Pharmaceutical Conferences

24th World Congress on Pharmacology August 19-20, 2019 Vienna, Austria; 25th International Conference on Advanced Clinical Research and Clinical Trials September 16-17, 2019 Rome, Italy; 20th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Edinburgh, Scotland; 21st Annual European Pharma Congress May 20-22, 2019 Zurich, Switzerland; 19th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25- 26, 2019 Berlin, Germany; 6th International Conference and Exhibition on Natural Products and Medicinal Plants Research June 24-25, 2019 Vienna, Austria; 6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance June 03-04, 2019 London, UK; 22nd International Conference and Exhibition on Pharmaceutical Formulations July 04, 05 & 06, 2019 Valencia, Spain; 11th Annual Congress on Drug Formulation & Analytical Techniques November 11-12, 2019 Istanbul, Turkey; 7th European Biopharma Congress June 17-18, 2019 Stockholm, Sweden; 12th European Biosimilars Congress April 15-16, 2019 Berlin, Germany

Related Journals: Journal of Neuropharmacology | Journal of NeuroImmune Pharmacology | International Journal of Neuropharmacology | Neurochemistry & Neuropharmacology | Journal of Neuroscience and Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceuticl AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association, Maryland Pharmacists Association

Track 03: Neuroethics

It includes the social, legal and ethical consequences of advances in neuroscience. It is the amalgamation of neuroscience with ethical thoughts. The ethics of neurocognitive includes brain interventions and imagining, neurological treatments and consciousness disorders.

Related ConferencesNeuropharmacology Conferences | Pharmacology Conferences | Neuropharmacology Conferences 2019 | Global Neuropharmacology Meeting | Clinical Neuropharmacology | Pharmaceutical Conferences

24th World Congress on Pharmacology August 19-20, 2019 Vienna, Austria; 25th International Conference on Advanced Clinical Research and Clinical Trials September 16-17, 2019 Rome, Italy; 20th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Edinburgh, Scotland; 21st Annual European Pharma Congress May 20-22, 2019 Zurich, Switzerland; 19th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25- 26, 2019 Berlin, Germany; 6th International Conference and Exhibition on Natural Products and Medicinal Plants Research June 24-25, 2019 Vienna, Austria; 6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance June 03-04, 2019 London, UK; 22nd International Conference and Exhibition on Pharmaceutical Formulations July 04, 05 & 06, 2019 Valencia, Spain; 11th Annual Congress on Drug Formulation & Analytical Techniques November 11-12, 2019 Istanbul, Turkey; 7th European Biopharma Congress June 17-18, 2019 Stockholm, Sweden; 12th European Biosimilars Congress April 15-16, 2019 Berlin, Germany

Related Journals: Journal of Neuropharmacology | Journal of NeuroImmune Pharmacology | International Journal of Neuropharmacology | Neurochemistry & Neuropharmacology | Journal of Neuroscience and Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaTurkish Pharmacists AssociationUtah Pharmaceutical Association, Kuwait Pharmaceuticl AssociationMaryland Pharmacists Association

Track 04: Clinical Neuropharmacology

It is the science that studies the features, properties, responses and uses of drugs mainly their therapeutic effect in humans along with toxicologypharmacodynamis and pharmacokinetics. It also includes drug abuse, pain and hypothalamic releasing factors.

Related ConferencesNeuropharmacology Conferences | Pharmacology Conferences | Neuropharmacology Conferences 2019 | Global Neuropharmacology Meeting | Clinical Neuropharmacology | Pharmaceutical Conferences

24th World Congress on Pharmacology August 19-20, 2019 Vienna, Austria; 25th International Conference on Advanced Clinical Research and Clinical Trials September 16-17, 2019 Rome, Italy; 20th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Edinburgh, Scotland; 21st Annual European Pharma Congress May 20-22, 2019 Zurich, Switzerland; 19th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25- 26, 2019 Berlin, Germany; 6th International Conference and Exhibition on Natural Products and Medicinal Plants Research June 24-25, 2019 Vienna, Austria; 6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance June 03-04, 2019 London, UK; 22nd International Conference and Exhibition on Pharmaceutical Formulations July 04, 05 & 06, 2019 Valencia, Spain; 11th Annual Congress on Drug Formulation & Analytical Techniques November 11-12, 2019 Istanbul, Turkey; 7th European Biopharma Congress June 17-18, 2019 Stockholm, Sweden; 12th European Biosimilars Congress April 15-16, 2019 Berlin, Germany

Related Journals: Journal of Neuropharmacology | Journal of NeuroImmune Pharmacology | International Journal of Neuropharmacology | Neurochemistry & Neuropharmacology | Journal of Neuroscience and Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association, Kuwait Pharmaceuticl Association

Track 05: Psychopharmacology

Psychopharmacology is the learning of the effects of medication on the psyche (psychology), observing changed behaviours and how molecular events are manifest in a measurable behavioural form. Neurogenesis and repair deal with other aspects on the indications for medications prescribed to address psychiatric and behavioural problems. The treatments may cause side effects such as induction of the metabolic syndrome, type II diabetes related to the medications prescribed for management of psychiatric and behavioural disorders and disturbances. Schizophrenia is such a disorder which affects the thinking and acting ability of a person caused by viral infection, genetically or by immune disorder.

Related ConferencesNeuropharmacology Conferences | Pharmacology Conferences | Neuropharmacology Conferences 2019 | Global Neuropharmacology Meeting | Clinical Neuropharmacology | Pharmaceutical Conferences

24th World Congress on Pharmacology August 19-20, 2019 Vienna, Austria; 25th International Conference on Advanced Clinical Research and Clinical Trials September 16-17, 2019 Rome, Italy; 20th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Edinburgh, Scotland; 21st Annual European Pharma Congress May 20-22, 2019 Zurich, Switzerland; 19th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25- 26, 2019 Berlin, Germany; 6th International Conference and Exhibition on Natural Products and Medicinal Plants Research June 24-25, 2019 Vienna, Austria; 6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance June 03-04, 2019 London, UK; 22nd International Conference and Exhibition on Pharmaceutical Formulations July 04, 05 & 06, 2019 Valencia, Spain; 11th Annual Congress on Drug Formulation & Analytical Techniques November 11-12, 2019 Istanbul, Turkey; 7th European Biopharma Congress June 17-18, 2019 Stockholm, Sweden; 12th European Biosimilars Congress April 15-16, 2019 Berlin, Germany

Related Journals: Journal of Neuropharmacology | Journal of NeuroImmune Pharmacology | International Journal of Neuropharmacology | Neurochemistry & Neuropharmacology | Journal of Neuroscience and Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association, Kuwait Pharmaceuticl Association

Track 06: Neurochemical Transmission

Neurochemistry is the specific study of neurochemicals, including neurotransmitters and other molecules that include psychopharmaceuticals, neuropeptides, or gastrotransmitters that influence the function of neurons. It also deals how these neurochemicals influence the network of neural operation. The studies include micro-macro connection between the analysis of organic compounds active in the nervous system and neural processes such as cortical plasticity, neurogenesis and neural differentiation, synapses, autism and intellectual disability, interneuronal coordination, interaction of drugs and its effect on summation and cotransmission process and advances in astrocyte-neuron interactions in health. Astrocyte dysfunction results into neurodegenerative diseases, stroke, epilepsy, and migraine and neuroinflammatory diseases.

Related ConferencesNeuropharmacology Conferences | Pharmacology Conferences | Neuropharmacology Conferences 2019 | Global Neuropharmacology Meeting | Clinical Neuropharmacology | Pharmaceutical Conferences

24th World Congress on Pharmacology August 19-20, 2019 Vienna, Austria; 25th International Conference on Advanced Clinical Research and Clinical Trials September 16-17, 2019 Rome, Italy; 20th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Edinburgh, Scotland; 21st Annual European Pharma Congress May 20-22, 2019 Zurich, Switzerland; 19th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25- 26, 2019 Berlin, Germany; 6th International Conference on Natural Products and Medicinal Plants Research June 24-25, 2019 Vienna, Austria; 6th World Congress on Antibiotics and Antibiotic Resistance June 03-04, 2019 London, UK; 22nd International Conference and Exhibition on Pharmaceutical Formulations July 04, 05 & 06, 2019 Valencia, Spain; 11th Annual Congress on Drug Formulation & Analytical Techniques November 11-12, 2019 Istanbul, Turkey; 7th European Biopharma Congress June 17-18, 2019 Stockholm, Sweden; 12th European Biosimilars Congress April 15-16, 2019 Berlin, Germany

Related Journals: Journal of Neuropharmacology | Journal of NeuroImmune Pharmacology | International Journal of Neuropharmacology | Neurochemistry & Neuropharmacology | Journal of Neuroscience and Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaTurkish Pharmacists AssociationMaryland Pharmacists Association, Utah Pharmaceutical Association, Kuwait Pharmaceuticl Association  

Track 07: Behavioral and Addiction Neuropharmacology

It is the study of drug dependence and how drug addiction affects the human mind, anxiety and autism, Measuring neural activity in Drug abuse, Alcoholism- tolerance to and physical dependence, and properties are mediated through its effects on dopamine neurons in the mesolimbic reward pathway, which connects the ventral tegmental area to the nucleus accumbens, Post-traumatic stress disorder and borderline personality disorder, clinical depression and enhanced treatments.

Related ConferencesNeuropharmacology Conferences | Pharmacology Conferences | Neuropharmacology Conferences 2019 | Global Neuropharmacology Meeting | Clinical Neuropharmacology | Pharmaceutical Conferences

24th World Congress on Pharmacology August 19-20, 2019 Vienna, Austria; 25th International Conference on Advanced Clinical Research and Clinical Trials September 16-17, 2019 Rome, Italy; 20th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Edinburgh, Scotland; 21st Annual European Pharma Congress May 20-22, 2019 Zurich, Switzerland; 19th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25- 26, 2019 Berlin, Germany; 6th International Conference and Exhibition on Natural Products and Medicinal Plants Research June 24-25, 2019 Vienna, Austria; 6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance June 03-04, 2019 London, UK; 22nd International Conference and Exhibition on Pharmaceutical Formulations July 04, 05 & 06, 2019 Valencia, Spain; 11th Annual Congress on Drug Formulation & Analytical Techniques November 11-12, 2019 Istanbul, Turkey; 7th European Biopharma Congress June 17-18, 2019 Stockholm, Sweden; 12th European Biosimilars Congress April 15-16, 2019 Berlin, Germany

Related Journals: Journal of Neuropharmacology | Journal of NeuroImmune Pharmacology | International Journal of Neuropharmacology | Neurochemistry & Neuropharmacology | Journal of Neuroscience and Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceuticl AssociationMaryland Pharmacists Association, Turkish Pharmacists AssociationUtah Pharmaceutical Association

Track 08: Neurotechnology and its Advances

It is the measurement and analysis of chemical and electrical signals of nervous system. It includes neurocircuitary analysis, novel trans-synaptic tracing approaches, advancements of optical techniques, neuromodulation and transcranial magnetic stimulation. Neurotechnology plays a crucial role in diagnostics and identification of nervous activities.

Related ConferencesNeuropharmacology Conferences | Pharmacology Conferences | Neuropharmacology Conferences 2019 | Global Neuropharmacology Meeting | Clinical Neuropharmacology | Pharmaceutical Conferences

24th World Congress on Pharmacology August 19-20, 2019 Vienna, Austria; 25th International Conference on Advanced Clinical Research and Clinical Trials September 16-17, 2019 Rome, Italy; 20th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Edinburgh, Scotland; 21st Annual European Pharma Congress May 20-22, 2019 Zurich, Switzerland; 19th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25- 26, 2019 Berlin, Germany; 6th International Conference and Exhibition on Natural Products and Medicinal Plants Research June 24-25, 2019 Vienna, Austria; 6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance June 03-04, 2019 London, UK; 22nd International Conference and Exhibition on Pharmaceutical Formulations July 04, 05 & 06, 2019 Valencia, Spain; 11th Annual Congress on Drug Formulation & Analytical Techniques November 11-12, 2019 Istanbul, Turkey; 7th European Biopharma Congress June 17-18, 2019 Stockholm, Sweden; 12th European Biosimilars Congress April 15-16, 2019 Berlin, Germany

Related Journals: Journal of Neuropharmacology | Journal of NeuroImmune Pharmacology | International Journal of Neuropharmacology | Neurochemistry & Neuropharmacology | Journal of Neuroscience and Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceuticl AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association, Maryland Pharmacists Association

Track 09: Neuroendocrinology

It is the study of interactions between the nervous system and the endocrine system, also biological features of the cells involved and their communications. Most Important aspects of neuroendocrinology are insulin receptor and hypothalamic programming; stress, coping and interactions, neuro-endocrine-immune symphony, pituitary structure and hormone secretion.

Related ConferencesNeuropharmacology Conferences | Pharmacology Conferences | Neuropharmacology Conferences 2019 | Global Neuropharmacology Meeting | Clinical Neuropharmacology | Pharmaceutical Conferences

24th World Congress on Pharmacology August 19-20, 2019 Vienna, Austria; 25th International Conference on Advanced Clinical Research and Clinical Trials September 16-17, 2019 Rome, Italy; 20th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Edinburgh, Scotland; 21st Annual European Pharma Congress May 20-22, 2019 Zurich, Switzerland; 19th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25- 26, 2019 Berlin, Germany; 6th International Conference and Exhibition on Natural Products and Medicinal Plants Research June 24-25, 2019 Vienna, Austria; 6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance June 03-04, 2019 London, UK; 22nd International Conference and Exhibition on Pharmaceutical Formulations July 04, 05 & 06, 2019 Valencia, Spain; 11th Annual Congress on Drug Formulation & Analytical Techniques November 11-12, 2019 Istanbul, Turkey; 7th European Biopharma Congress June 17-18, 2019 Stockholm, Sweden; 12th European Biosimilars Congress April 15-16, 2019 Berlin, Germany

Related Journals: Journal of Neuropharmacology | Journal of NeuroImmune Pharmacology | International Journal of Neuropharmacology | Neurochemistry & Neuropharmacology | Journal of Neuroscience and Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceuticl AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association, Maryland Pharmacists Association

Track 10: Alzheimer's Disease and Dementia

Alzheimer's is a type of dementia that causes problems with memory, thinking and behaviour. Symptoms usually develop slowly and become severe enough to interfere with daily tasks. Amyloid plaques are also found in the brain of Alzheimer patientsNeurocognitive effects associated with therapeutic drugs and animal cognition and behaviour - Fear and aversive learning and memory.

Related ConferencesNeuropharmacology Conferences | Pharmacology Conferences | Neuropharmacology Conferences 2019 | Global Neuropharmacology Meeting | Clinical Neuropharmacology | Pharmaceutical Conferences

24th World Congress on Pharmacology August 19-20, 2019 Vienna, Austria; 25th International Conference on Advanced Clinical Research and Clinical Trials September 16-17, 2019 Rome, Italy; 20th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Edinburgh, Scotland; 21st Annual European Pharma Congress May 20-22, 2019 Zurich, Switzerland; 19th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25- 26, 2019 Berlin, Germany; 6th International Conference and Exhibition on Natural Products and Medicinal Plants Research June 24-25, 2019 Vienna, Austria; 6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance June 03-04, 2019 London, UK; 22nd International Conference and Exhibition on Pharmaceutical Formulations July 04, 05 & 06, 2019 Valencia, Spain; 11th Annual Congress on Drug Formulation & Analytical Techniques November 11-12, 2019 Istanbul, Turkey; 7th European Biopharma Congress June 17-18, 2019 Stockholm, Sweden; 12th European Biosimilars Congress April 15-16, 2019 Berlin, Germany

Related Journals: Journal of Neuropharmacology | Journal of NeuroImmune Pharmacology | International Journal of Neuropharmacology | Neurochemistry & Neuropharmacology | Journal of Neuroscience and Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceuticl AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association, Maryland Pharmacists Association

Track 11: Parkinson Disease

It is a progressive and chronic disorder, caused by death or malfunctioning of neurons, genetic mutation leading to decreased level of dopamine secretion. Associated effects are anxiety; depression, stress, ageing and neurodegenerative disorders, disease diagnostics, drug designing and therapeutics are the research areas.

Related ConferencesNeuropharmacology Conferences | Pharmacology Conferences | Neuropharmacology Conferences 2019 | Global Neuropharmacology Meeting | Clinical Neuropharmacology | Pharmaceutical Conferences

24th World Congress on Pharmacology August 19-20, 2019 Vienna, Austria; 25th International Conference on Advanced Clinical Research and Clinical Trials September 16-17, 2019 Rome, Italy; 20th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Edinburgh, Scotland; 21st Annual European Pharma Congress May 20-22, 2019 Zurich, Switzerland; 19th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25-26, 2019 Berlin, Germany; 6th International Conference and Exhibition on Natural Products and Medicinal Plants Research June 24-25, 2019 Vienna, Austria; 6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance June 03-04, 2019 London, UK; 22nd International Conference and Exhibition on Pharmaceutical Formulations July 04, 05 & 06, 2019 Valencia, Spain; 11th Annual Congress on Drug Formulation & Analytical Techniques November 11-12, 2019 Istanbul, Turkey; 7th European Biopharma Congress June 17-18, 2019 Stockholm, Sweden; 12th European Biosimilars Congress April 15-16, 2019 Berlin, Germany

Related Journals: Journal of Neuropharmacology | Journal of NeuroImmune Pharmacology | International Journal of Neuropharmacology | Neurochemistry & Neuropharmacology | Journal of Neuroscience and Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of Australia, Maryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association, Kuwait Pharmaceuticl Association

Track 12: Molecular Neuropharmacology

Molecular neuropharmacology involves the study of neurons and agonist, Competitive antagonist and Non-competitive antagonist, receptors on neurons for developing new drugs that will treat neurological disorders of neurodegenerative diseases. Neurogenesis and repair refers to the growth and development of neuron. Neurons never function in isolation; they are organized into ensembles or circuits that process kinds of information which are referred as neuronal circuits. The GABA inhibitory neurotransmitter and serotonin neurotransmitter present in the central nervous system of mature vertebrate interacts with GABA receptor and 5HT receptor respectively. GABAA receptors are modulated by the channel of 5HT receptors through activation of various proteins. There are about 14 5HT receptor subtypes identified from last 20 years which are now researched for their significance in various disorders and treatments. Synaptopathy is a progressively popular term used to define main features of psychiatric and neurodegenerative diseases. It infers that brain diseases are resulted from disruption of synaptic structure and function.

Related ConferencesNeuropharmacology Conferences | Pharmacology Conferences | Neuropharmacology Conferences 2019 | Global Neuropharmacology Meeting | Clinical Neuropharmacology | Pharmaceutical Conferences|

24th World Congress on Pharmacology August 19-20, 2019 Vienna, Austria; 25th International Conference on Advanced Clinical Research and Clinical Trials September 16-17, 2019 Rome, Italy; 20th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Edinburgh, Scotland; 21st Annual European Pharma Congress May 20-22, 2019 Zurich, Switzerland; 19th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25- 26, 2019 Berlin, Germany; 6th International Conference and Exhibition on Natural Products and Medicinal Plants Research June 24-25, 2019 Vienna, Austria; 6th World Congress on Antibiotics and Antibiotic Resistance June 03-04, 2019 London, UK; 22nd International Conference and Exhibition on Pharmaceutical Formulations July 04, 05 & 06, 2019 Valencia, Spain; 11th Annual Congress on Drug Formulation & Analytical Techniques November 11-12, 2019 Istanbul, Turkey; 7th European Biopharma Congress June 17-18, 2019 Stockholm, Sweden; 12th European Biosimilars Congress April 15-16, 2019 Berlin, Germany

Related Journals: Journal of Neuropharmacology | Journal of NeuroImmune Pharmacology | International Journal of Neuropharmacology | Neurochemistry & Neuropharmacology | Journal of Neuroscience and Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences, Italian Society for Pharmaceutical Sciences (SISF) 

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceuticl AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association, Maryland Pharmacists Association

Track 13: Future Aspects of Neuropharmacology

Neuropharmacology is an emerging field of science, rising exponentially with the understanding of nervous system and its related disorders, drugs and treatments. The major area of research includes mechanisms of novel drugs, neuro stem cell therapyimmunoglobulin therapy, gene therapy in neuronal disorders and neural engineering.

Related ConferencesNeuropharmacology Conferences | Pharmacology Conferences | Neuropharmacology Conferences 2019 | Global Neuropharmacology Meeting | Clinical Neuropharmacology | Pharmaceutical Conferences

24th World Congress on Pharmacology August 19-20, 2019 Vienna, Austria; 25th International Conference on Advanced Clinical Research and Clinical Trials September 16-17, 2019 at Rome, Italy; 20th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Edinburgh, Scotland; 21st Annual European Pharma Congress May 20-22, 2019 Zurich, Switzerland; 19th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25-26, 2019 Berlin, Germany; 6th International Conference and Exhibition on Natural Products and Medicinal Plants Research June 24-25, 2019 Vienna, Austria; 6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance June 03-04, 2019 London, UK; 22nd International Conference and Exhibition on Pharmaceutical Formulations July 04, 05 & 06, 2019 Valencia, Spain; 11th Annual Congress on Drug Formulation & Analytical Techniques November 11-12, 2019 Istanbul, Turkey; 7th European Biopharma Congress June 17-18, 2019 Stockholm, Sweden; 12th European Biosimilars Congress April 15-16, 2019 Berlin, Germany

Related Journals: Journal of Neuropharmacology | Journal of NeuroImmune Pharmacology | International Journal of Neuropharmacology | Neurochemistry & Neuropharmacology | Journal of Neuroscience and Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Belgian Society of Pharmaceutical Sciences, Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS) 

Societies in Asia: The Pharmaceutical Society of AustraliaMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association, Kuwait Pharmaceuticl Association

Market Analysis

Summary: Neuropharmacology 2019 welcomes attendees, presenters, and exhibitors from all over the world to Rome, Italy. We are delighted to invite you all to attend and register for the “27th Global Experts Meeting on Neuropharmacology (Neuropharmacology 2019)” which is going to be held during November 18-19, 2019 Rome, Italy. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Neuropharmacology-2019, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Neuropharmacology 2018 organizing committee look forward to meet you at Rome, Italy.

For more details please visit   http://neuro.pharmaceuticalconferences.com/

Importance and Scope:  Neuropharmacology is the study of how drugs influence cellular function in the nervous system, and the neural mechanisms through which they influence behaviour. The studies are more concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Advanced studies are being made to improvise developments in drugs to treat numerous diverse neurological disorders, including neurodegenerative diseases known to be Parkinson's disease and Alzheimer's disease, pain, addiction, psychological disorders and many more.

Comparative analysis for Neurological Disorders (Age wise profile)

Conference Highlights

  • Neuroimmunology and Neuroinflammation
  • Neural Stem Cell
  • Molecular Neuropharmacology
  • Clinical Neuropharmacology
  • Psychopharmacology
  • Neurochemical Transmission
  • Behavioral and Addiction Neuropharmacology
  • Neurotechnology
  • Neuroendocrinology
  • Alzheimer’s Disease and Dementia
  • Parkinson’s Disease
  • Neuroethics
  • Future Aspects of Neuropharmacology
  • Case Study Reports

Attendance Profile according to specialization in a Neuroscience Conference

Hospitals of Neuropharmacology

Top Hospitals

  • Mayo Clinic, Rochester, Minnesota
  • Johns Hopkins Hospital, Baltimore, Maryland
  • Massachusetts General Hospital, Boston
  • University of California–San Francisco Medical Center
  • Mathodist Hospital, San Antonio
  • University of California–Los Angeles Medical Center
  • New York University Langone Medical Center, New York City
  • Hospitals of the University of Pennsylvania–Penn Presbyterian
  • Northwestern Memorial Hospital, Chicago
  • Baptist Medical Centre, San Antonio

 Major Neuropharmacology related Associations around the Globe

  • Canadian Neurological Sciences Federation
  • European Parkinson’s disease Association
  • Malaysian Society of Neurosciences
  • Eurospine, The Spine Society Of Europe
  • The Spanish Society of Neurology (SEN)
  • The Czech Neuropsychopharmacological Society
  • Belgian Neurological Society
  • National Neurotrauma Society
  • National Parkinson'S Foundation
  • European Society Of Neurosonology And Cerebral Hemodynamics
  • Federation Of European Neuroscience Societies
  • Malaysian Society Of Neurosciences
  • Česká Neurologická Společnost
  • The Czech Neuropsychopharmacological Society
  • European Academy Of Neurology
  • Deutsche Gesellschaft Fur Neurologieologie
  • International Brain Research Organization
  • The Neuropathy Association
  • The Primary Care Neurology Society
  • The Spanish Society Of Neurology (SEN)

Major Neuropharmacology related Associations

  • International Neuroethics Society
  • Society for Behavioral Neuroendocrinology
  • Society For Neuroscience
  • American Psychological Association
  • International Parkinson and Movement Disorder Society
  • American Neurological Association
  • National Institute Of Environmental Health Sciences
  • The American Society of Neuroimaging
  • American Board Of Psychiatry And Neurology, Inc.
  • American Clinical Neurophysiology Society
  • International Neuropsychological Society
  • Southern Clinical Neurological Society
  • International Parkinson And Movement Disorder Society

Products for Neurological Treatments

This above statistic displays the global revenue of Abilify from Bristol-Myers Squibb from 2011 to 2014. In the United States alone, Abilify generated a revenue of 2.1 million U.S. dollars in 2012. Abilify is an antipsychotic agent that is used to treat various conditions such as schizophrenia, bipolar mania disorder, and major depressive disorder.

Gross Profit Margin of Neuropharmaceutical related companies

Market Capitalization of Neuropharmaceutical companies: In 2014, investors provided $3.3 billion into firms that are developing drugs for brain-destroying or psychiatric illnesses. Some big drug companies, including Johnson & Johnson, Roche and Novartis, are finding ways to reinvigorate their efforts. New medicines for severe depression, psychosis and schizophrenia could reach the market within the next few years, and treatments for Alzheimer’s, Parkinson’s and some forms of autism are a real possibility, too.

Sales Profile of Neuropharmaceutical companies

Research Fund: NIH (National Institute of Health) and NSFC (Nature Science Foundation of China) provided fund for the neurological disorders such as dementia, schizophrenia, stroke, parkinson’s, epilepsy.

Institutes funding for research

  1. The US National Institutes of Health fund a Neuropharmacology Laboratory project, Universitat Pompeu Fabra, Barcelona
  2. Neuropharmacology Program, The National Institute of Mental Health (NIMH)
  3. McKnight Endowment Fund for Neuroscience
  • The statistic depicts the research and development expenditure of the entire pharmaceutical industry of the United States from 1995 to 2014. In 2004, the expenditure of the entire U.S. pharmaceutical industry on research and development came to 47.6 billion U.S. dollars.

Past Conference Report

Neuropharmacology 2018

Neuropharmacology 2018 Report

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Neuropharmacology 2018 Conference the best ever!

The 9th Global Experts Meeting on Neuropharmacology, hosted by the Conference Series LLC  Ltd was held during November 15-16, 2018 at Best Western Premier Airporthotel Fontane Berlin, Germany based on the theme Neuropharmacology: Major Challenges and Breakthroughs". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Neuropharmacology, who made this event a grand success. 

Know more at Neuropharmacology 2018 Proceedings

Conference Series LLC Ltd expresses its gratitude to the conference Moderator and Chair namely Dr. Philip Timms , Dr. Wilfried Dimpfel for taking up the responsibility to coordinate during the sessions. We are indebted to your support.

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

  • Hari Shanker Sharma, Uppsala University, Sweden
  • Mehrdad Shamloo, Stanford University, USA

We are grateful to our Speakers of Special session. The list comprises:

  • Wilfried Dimpfel, Justus Liebig University Giessen, Germany
  • Olga Malyshevskaya, Tsukuba University, Japan
  • Kudret Esen Gumuslu, Kocaeli University, Turkey
  • Aruna Sharma, Uppsala University, Sweden
  • Eva Kudova, Institute of Organic Chemistry and Biochemistry – ASCR, Czech Republic

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

  • Neuroimmunology and Neuroinflammation
  • Clinical Neuropharmacology
  • Neurochemical Transmission
  • Molecular Neuropharmacology
  • Parkinson’s Disease
  • Alzheimer’s Disease and Dementia
  • Psychopharmacology
  • Behavioral and Addiction Neuropharmacology
  • Neural Stem Cell
  • Neuroethics
  • Neurotechnology and its Advances
  • Neuroendocrinology
  • Future Aspects of Neuropharmacology

Conference Series LLC Ltd  offers its heartfelt appreciation to organizations such as Bio-Equip CourseForDoctors.com AvoTravel CrowdReviews  iCause Kindcongress Manuscriptedit PharmaVOICE Pink Medico Swiss Biotech Tabeeby  Times International and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. Conference Series LLC Ltd also took privilege to felicitate the Keynote Speakers, Organizing Committee Members and Chairs who supported this event.

With the grand success of Neuropharmacology 2018, Conference Series LLC Ltd  is proud to announce the 27th Global Experts Meeting on Neuropharmacology" to be held during November 18-19, 2019 at Rome, Italy

For More details visit: http://neuro.pharmaceuticalconferences.com/


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 18-19, 2019

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Neuropharmacology: Open Access Journal of Neurological Disorders Journal of Neurology & Neurophysiology International Journal of Neurorehabilitation

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Keytopics

  • Acute Stress Disorder
  • Addiction Psychiatry
  • Adolescent Anxiety
  • Alcoholic Neuropathy
  • Alexander Disease
  • Amyotrophic Lateral Sclerosis
  • Anosognosia
  • Autism
  • Biomarkers Forbrain
  • Bipolar Affective Disorders
  • Brain Injury Rehabilitation
  • Brain Mapping
  • Brain Scan
  • Brain Stem
  • Brain Stimulation
  • Brain Tumor
  • Cavernous Malformations
  • Cerebral Palsy
  • Child Psychology
  • Childhood Anxiety
  • Cognitive Psychology
  • Dementia
  • Depression Disorders
  • Dopamine
  • Dyslexia
  • Dysthemia
  • Encephalitis
  • Epilepsy
  • Hippocampus
  • Hydrocephalus
  • Hypersomnia
  • Insomnia
  • MRI Research Of The Developing Brain
  • Multiple Sclerosis
  • Narcolepsy
  • Nerve Injury
  • Neural Model
  • Neural Tube Disorders
  • Neuro Drug Delivery
  • Neuro Vascular Diseases
  • Neuro-Oncology
  • Neuroblastoma
  • Neurocysticercosis
  • Neurodegeneration
  • Neuroendocrine Immunology
  • Neurogenomics
  • Neuroimage
  • Neuroinflammation
  • Neurological Physiotherapy
  • Neuromodulation
  • Neuromyelitis Optica
  • Neuron
  • Neuropathy
  • Neuroregeneration
  • Neurosarcoidosis
  • Neurosyphilis
  • Novel Therapeutics In Neurosciences
  • Parkinsonism Gene Therapy
  • Pituitary
  • Post Traumatic Disorders
  • Schizophrenia
  • Serotonin
  • Spina Bifida
  • Spinal Cord
  • Stem Cell Treatment Parkinson
  • StrokeRehabilitation
  • Therapeutics Of Sleep Disorders
  • Toxoplasmosis
  • Traumatic Brain Injury